Edition:
United Kingdom

People: Enzo Biochem Inc (ENZ.N)

ENZ.N on New York Stock Exchange

3.63USD
22 Apr 2019
Change (% chg)

-- (--)
Prev Close
$3.63
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
46,396
52-wk High
$6.88
52-wk Low
$2.33

Rabbani, Elazar 

Dr. Elazar Rabbani, Ph.D. is the Chairman of the Board, Chief Executive Officer, Secretary of the Company. He has authored numerous scientific publications in the field of molecular biology, in particular, nucleic acid labeling and detection. He is also the lead inventor of many of the Company’s pioneering patents covering a wide range of technologies and products. Dr. Rabbani received his Bachelor of Arts degree from New York University in Chemistry and his Ph.D. in Biochemistry from Columbia University. He is a member of the American Society for Microbiology.

Basic Compensation

Total Annual Compensation, USD 611,000
Restricted Stock Award, USD 44,200
Long-Term Incentive Plans, USD --
All Other, USD 821,472
Fiscal Year Total, USD 1,476,670

Options Compensation

  Quantity Market Value
Exercisable 535,221 2,723,090.00
Unexercisable 55,125 249,998.00
Exercised 63,814 206,821.00
Name Fiscal Year Total

Barry Weiner

1,246,880

Elazar Rabbani

1,476,670

James O'Brien

494,722

Bruce Dey

496,496

Dieter Schapfel

470,076

Gregory Bortz

197,500
As Of  31 Jul 2018